Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
642 In a multicenter, randomized, double-blind, placebo-controlled phase-3 clinical trial conducted in China, acetyllevocarnitine hydrochloride treatment for 24 weeks significantly improved symptoms and somatosensory symptoms in patients with DPN, with a treatment effect of 65% higher than placebo
The most optimistic realistic timeline for private UK availability is late 2027
the paid live-visit add-on is unusual at this price tier
Subgroup Sensitivity Analysis A subgroup of 1864 participants with available demographic and baseline data allowed for a more detailed sensitivity analysis (Table S1 in Multimedia Appendix 1)
US$ 21.50
US$ 28.09
US$ 27.68
US$ 20.75
US$ 22.29
US$ 25.82
US$ 24.00
US$ 27.38
US$ 20.50
US$ 21.30
US$ 24.24
US$ 22.42
